Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.

Kevin Osteen, Ph.D., Pierre Soupart Professor Obstetrics and Gynecology, and his team at the Women’s Reproductive Health Research Center have developed a three-dimensional organ-on-a-chip cell model that mimics the endometrial lining of the uterus in an effort to test therapeutic interventions for reproductive diseases.

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.

Children who experience recurrent C. diff infections may have fecal inflammatory markers that could predict risk and improve management of these infections.

Two brain signaling pathways have overlapping functions in regulating anxiety, suggesting that therapeutics aimed at one or the other will impact both.

Vanderbilt investigators have identified an unexpected link between cell survival and the polarized delivery of proteins to the surface of mammary epithelial cells.

A new protein structure may guide the development of Alzheimer's therapeutics.